1 / 1

A : Tumor progression in C57BL/6 Mice

In vivo Analysis. A : Tumor progression in C57BL/6 Mice. 600. 500. 400. B16.F10. B16.F10 TFG HTLV-1 ZEO. 300. B16.F10 TFG FGF-2 ZEO. Mean tumor size (mm2). B16.F10 TFG EMCV ZEO. 200. B16.F10 DFG70 and DFG80. 100. 0. 0. 4. 8. 12. 15. 19. Days. B : Tumor progression in BALB/c.

baird
Download Presentation

A : Tumor progression in C57BL/6 Mice

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. In vivo Analysis A : Tumor progression in C57BL/6 Mice 600 500 400 B16.F10 B16.F10 TFG HTLV-1ZEO 300 B16.F10 TFGFGF-2ZEO Mean tumor size (mm2) B16.F10 TFGEMCVZEO 200 B16.F10 DFG70 and DFG80 100 0 0 4 8 12 15 19 Days B : Tumor progression in BALB/c 140 TS/A WT 120 100 TS/A TFGEMCVZEO 80 CD70) (23%CD70 and CD80, 34% Mean tumor size (mm2) 60 TS/A TFGFGF-2ZEO 40 (17%CD70 and CD80, 73 % CD70) 20 TS/A DFG70 and DFG80 0 (68% CD70 and CD80) -20 0 7 11 17 21 Days

More Related